Sponsored Links

Rockwell Medical's iron deficiency drug succeeds in trial

July 11 | Thu Jul 11, 2013 6:39am EDT

July 11 (Reuters) - Rockwell Medical Inc said a late-stage trial of its experimental iron deficiency drug met the main goal of improving patients' hemoglobin levels.

The study was the first of two planned late-stage trials, and tested the drug, SFP, in adult patients with chronic kidney disease.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.